Structured evidence table for Hyaluronic Acid Joint Health Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Hyaluronic Acid Joint Health Randomized Trial | 25 37 13 5 Hip OA is a major cause of pain, leading to significant mobility limitations, reduced physical capacity and severe impact on the patient's quality of life. | 2 | de Sire Alessandro (2026) | Combined ultrasound‐guided hyaluronic acid injections, high‐power laser therapy and physiotherapy improve hip function in osteoarthritis: A randomized controlled trial |
| Hyaluronic Acid Joint Health Randomized Trial | However, the literature offers few studies, and those available present conflicting results regarding postural changes associated with hip joint damage []. | 2 | de Sire Alessandro (2026) | Combined ultrasound‐guided hyaluronic acid injections, high‐power laser therapy and physiotherapy improve hip function in osteoarthritis: A randomized controlled trial |
| Hyaluronic Acid Joint Health Randomized Trial | Patients with BMI > 30 were excluded to avoid confounding factors related to excessive mechanical load and reduced rehabilitation adherence; suspension of anti‐inflammatory drugs (NSAIDs), opioids, corticosteroids, muscle relaxants or any other therapy that could interfere with the study assessments. | 2 | de Sire Alessandro (2026) | Combined ultrasound‐guided hyaluronic acid injections, high‐power laser therapy and physiotherapy improve hip function in osteoarthritis: A randomized controlled trial |
| Hyaluronic Acid Joint Health Randomized Trial | 28 13 41 The hip joint is one of the primary joints commonly affected by degenerative osteoarthritis (OA) []. | 2 | de Sire Alessandro (2026) | Combined ultrasound‐guided hyaluronic acid injections, high‐power laser therapy and physiotherapy improve hip function in osteoarthritis: A randomized controlled trial |
| Hyaluronic Acid Joint Health Randomized Trial | These findings provided high-level evidence challenging the clinical benefit of cross-linked HAs. | 2 | Kanitnate S (2026) | Efficacy of Ultra-high and High Molecular Weight Cross-Linked Hyaluronic Acids Compared with Saline in Knee Osteoarthritis: A Randomized Controlled Trial. |
| Hyaluronic Acid Joint Health Randomized Trial | Introduction Intra-articular hyaluronic acid (HA) injections are widely used for knee osteoarthritis (OA) to reduce pain and improve function. | 2 | Kanitnate S (2026) | Efficacy of Ultra-high and High Molecular Weight Cross-Linked Hyaluronic Acids Compared with Saline in Knee Osteoarthritis: A Randomized Controlled Trial. |
| Hyaluronic Acid Joint Health Randomized Trial | This study aimed to compare the efficacy of 2 single-injection, ultra-high, and high molecular weight (HMW) cross-linked HAs against a saline placebo for symptomatic knee OA. | 2 | Kanitnate S (2026) | Efficacy of Ultra-high and High Molecular Weight Cross-Linked Hyaluronic Acids Compared with Saline in Knee Osteoarthritis: A Randomized Controlled Trial. |
Source documents